Drug Type Growth factors |
Synonyms FGFR21 fusion protein(Tasly Pharmaceutical Group) |
Target |
Action modulators |
Mechanism FGF21 modulators(Fibroblast growth factor 21 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | China | - | |
Diabetes Mellitus, Type 2 | Preclinical | United States | - | |
Nonalcoholic Steatohepatitis | Preclinical | United States | - | |
Nonalcoholic Steatohepatitis | Preclinical | China | - |